Search results
Results from the WOW.Com Content Network
1990 Deutsche Bank: Morgan Grenfell: Deutsche Bank: 1993 Primerica: Shearson Lehman Hutton (Brokerage and Asset Management) Primerica (Smith Barney Shearson) 1993 Lehman Brothers (Spinoff from American Express) Shearson Lehman Hutton: Lehman Brothers: 1995 Paine Webber: Kidder, Peabody & Co. PaineWebber Group: 1995 Swiss Bank Corporation: S. G ...
Chiron was the first to clone HCV in 1989 after six years of research [8] and had since filed over 100 HCV related patents in over 20 countries. [31] A settlement was reached where Roche Holding A.G. agreed to buy the global semi-exclusive nucleic acid test (NAT) patents for HCV and HIV from Chiron. [25]
Novartis also initiated a program to assist patients who could not afford its version of the drug, concurrent with its product launch. [175] When examination of Novartis' patent application began in 2005, it came under immediate attack from oppositions initiated by generic companies that were already selling Gleevec in India and by advocacy ...
With another earnings season upon us, The Fool's health care team is busy making sure investors know what to expect from their favorite companies this quarter, while also maintaining a focus on ...
The Swiss competition commission (COMCO) has initiated an investigation against Novartis AG (NYSE: NVS) over the alleged unlawful patent use to reduce competitive pressure. COMCO conducted an ...
Swiss drug major Novartis AG (NYSE: NVS) plans to petition the U.S. Supreme Court to uphold the validity of the Gilenya (fingolimod) dosing regimen patent. The decision comes as the U.S. Court of ...
Novartis v. Union of India & Others is a landmark decision by a two-judge bench of the Indian Supreme Court on the issue of whether Novartis could patent Gleevec in India, and was the culmination of a seven-year-long litigation fought by Novartis. The Supreme Court upheld the Indian patent office's rejection of the patent application.
Pfizer has faced patent-cliff issues of its own, as the expiration of its Lipitor patent has caused a massive drop in Lipitor's sales. The company has tried to make up for the loss in revenue by ...